The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The most recent trading session ended with Moderna (MRNA) standing at $24.73, reflecting a -1.85% shift from the previouse trading day's closing. The stock's performance was behind the S&P 500's daily ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...

Leerink Partners analyst David Risinger maintained a Sell rating on Moderna (MRNA – Research Report) yesterday and set a price target of ...

Guidelines from the Advisory Committee on Immunization Practices help physicians decide what vaccines to recommend to patients and are also used for determining insurance coverage in the U.S. The ...

The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

US mRNA specialist Moderna (Nasdaq: MRNA) has announced that its manufacturing facility in the UK has been granted a manufacturer’s license by the Medicines and Healthcare products Regulatory Agency ...

The U.S. Centers for Disease Control and Prevention's outside panel of vaccine experts on Tuesday discussed narrowing ...

With petrol cars being banned in five years time is there still room for a £227,570 V6-powered supercar? Express reporter ...

Learn more about whether Legend Biotech Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.